MetGen is a Finland-based biotechnology startup founded in 2008. The company specializes in designing and marketing novel enzymatic solutions for the most challenging industrial conditions. Their flagship product, MetZyme®, is a highly-active, natural catalyst that can survive in harsh industrial environments, enabling novel applications and combinations with other enzymes. MetGen's products are protected by international patents.
The company focuses on offering customized projects to meet customer's specific needs by utilizing advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and handle a variety of lignocellulosic substrates. MetGen has successfully conducted industrial trials with sector leaders in the forest and renewable chemicals industry.
In 2014, MetGen Oy received the Best in BioFuel / BioEnergy category award from the Global Cleantech Cluster Association (GCCA) for its innovative solutions. The company's latest investment of €500.00K was secured through a Venture Round at 29 January 2019.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | €500.00K | - | 29 Jan 2019 | |
| Corporate Round | Unknown | 1 |
|
19 Dec 2017 |
| Grant | €1.54M | 1 | EASME - EU Executive Agency for SMEs | 01 Apr 2015 |
| Series A | Unknown | 5 |
|
05 Jun 2013 |
| Venture Round | €2.20M | 3 |
|
11 Feb 2013 |
No recent news or press coverage available for MetGen.
We care about your data, and we'd love to use cookies make your experience better.
